Medline has particularly acquired the manufacturing and laboratory assets, and assumed the lease, on Perrigo’s plant in Lake Worth, Florida, US. Medline will manufacture a number of personal
The Phase 4, multicenter study has met the primary endpoint, the proportion of subjects with a 50% or more reduction in sperm concentration from baseline to end of
XP23829 is a novel fumarate analog for the potential treatment of relapsing-remitting multiple sclerosis and psoriasis, which demonstrated a greater degree of efficacy compared to Dimethyl fumarate in
Boehringer is responsible for all further research, development and commercialization of FX125L, to treat a range of inflammatory diseases. Financial details of the transaction were kept confidential. Boehringer
The research and development project will leverage Pacific Biosciences’ proprietary zero-mode waveguide (ZMW) technology and imec’s knowledge in nanophotonics, CMOS sensors, technology integration and fabrication. Pacific Biosciences president
Servier and Galapagos entered into an alliance in July 2010 to develop new oral medicines for the treatment of osteoarthritis (OA). The identification of the new compound, which
With the completion of the acquisition, Fougera will be integrated into Sandoz’s US business based in Princeton, New Jersey, but will continue to exist as a separate legal
Bio Life Solutions CEO Mike Rice said the company’s new corporate facilities and expanded operations and support areas will enable it to increase production of platform HypoThermosol and
Used with Abbott’s fully automated ARCHITECT immunochemistry instrument platform, the test measures a patient’s blood level of galectin-3, a protein that progresses heart failure. The new application is
If the CHMP recommendation is adopted by the European Commission, brentuximab vedotin, an antibody-drug conjugate (ADC), will be used to treat patients with refractory CD30 positive Hodgkin lymphoma
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.